Quercetin Anti-Inflammatory Mechanisms: NLRP3, NF-κB, and Cytokines
Expert Summary
Quercetin's anti-inflammatory profile encompasses NLRP3 inflammasome inhibition (reducing IL-1β and IL-18 maturation), NF-κB nuclear translocation blockade (reducing inflammatory gene transcription), and direct inhibition of TNF-α, IL-6, and IL-8 production. Clinical RCTs confirm reductions in CRP and IL-6 with doses ≥500 mg/day.
Key Facts
- NLRP3 inflammasome inhibition: Quercetin inhibits NLRP3 assembly and activation at IC50 ~10 μM, reducing IL-1β processing and secretion. NLRP3 activation is a central driver of inflammaging — the chronic low-grade inflammation characteristic of aging.
- NF-κB inhibition: Quercetin blocks IκB phosphorylation, preventing NF-κB nuclear translocation. NF-κB regulates expression of hundreds of inflammatory genes including COX-2, iNOS, IL-6, IL-8, and TNF-α.
- SASP amplification of inflammation: Senescent cells use SASP partly via NF-κB-dependent IL-6 and IL-8 production. Quercetin's NF-κB inhibition reduces SASP output from both senescent and non-senescent inflammatory cells.
- Clinical CRP reduction: A 2014 meta-analysis found quercetin supplementation ≥500 mg/day reduced CRP by -0.33 mg/L on average. In subjects with elevated baseline CRP (>3 mg/L, high cardiovascular risk), reductions were substantially greater.
- Mast cell stabilization: Quercetin inhibits histamine release from mast cells and basophils via PLCΓ inhibition, providing antihistamine benefits alongside anti-inflammatory effects. This is the basis for quercetin's use in seasonal allergy management.
- Anti-inflammatory + senolytic synergy: Quercetin's direct anti-inflammatory effects complement its senolytic activity. By both eliminating SASP-producing senescent cells AND inhibiting inflammatory pathways in remaining cells, quercetin produces a double anti-inflammatory effect.
Recommended Products
Frequently Asked Questions
How does quercetin compare to NSAIDs for inflammation?
Quercetin is less potent than NSAIDs (ibuprofen, aspirin) for acute inflammation, but offers a more favorable chronic-use safety profile (no GI ulceration, no renal risk). Quercetin's NLRP3 and NF-κB inhibition provides broader mechanism coverage than COX-2-focused NSAIDs.
Can quercetin reduce chronic joint pain?
Several small RCTs show quercetin reduces inflammatory markers in osteoarthritis and rheumatoid arthritis patients. The anti-inflammatory and senolytic (cartilage senescent cell clearance) mechanisms both contribute. Effects are modest but cumulative with regular use.
Does quercetin reduce post-exercise inflammation beneficially or harmfully?
Exercise-induced inflammation is part of the adaptation signal. There is theoretical concern that quercetin taken immediately after exercise (during the acute inflammatory window) may blunt adaptations. Taking quercetin at least 12–24 hours before or after intense training is a practical approach.
Scientific References
- He L et al. Quercetin inhibits the inflammatory response by suppressing the IL-1β-induced SASP in human primary cells. Cellular Signaling. 2021.
- Boots AW et al. Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. 2008. PMID: 18417116